HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Indium 111In-satumomab pendetide

monoclonal antibody conjugate; OncoScint is labeled with 111In; used for detection and staging of colorectal neoplasms
Also Known As:
111In-CYT-103; B72.3-GYK-DTPA; B72.3-glycyl-tyrosyl N-diethylenetriaminepentacetic acid; CYT 103; CYT-103; OncoScint; OncoScint CR103
Networked: 44 relevant articles (2 outcomes, 8 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Adanja, G: 2 articles (07/2003 - 01/2003)
2. Artiko, V: 2 articles (07/2003 - 01/2003)
3. Petrovic, N: 1 article (07/2003)
4. Pesko, P: 1 article (07/2003)
5. Krivokapic, Z: 1 article (07/2003)
6. Davidovic, B: 1 article (07/2003)
7. Milosavljevic, T: 1 article (07/2003)
8. Djukic, V: 1 article (07/2003)
9. Obradovic, V: 1 article (07/2003)
10. Petrovic, M: 1 article (07/2003)

Related Diseases

1. Colorectal Neoplasms (Colorectal Cancer)
2. Ovarian Neoplasms (Ovarian Cancer)
3. Carcinoma (Carcinomatosis)
4. Adenocarcinoma
5. Neoplasm Metastasis (Metastasis)

Related Drugs and Biologics

1. Indium 111In-satumomab pendetide
2. Monoclonal Antibodies
3. tumor-associated antigen 72
4. iodinated vasoactive intestinal peptide
5. B72.3 antibody
6. Immunoconjugates (Immunoconjugate)
7. Immunoglobulin G (IgG)
8. Glycoproteins (Glycoprotein)
9. Antigens
10. Muromonab-CD3 (Muromonab CD3)

Related Therapies and Procedures

1. Radiotherapy
2. Intravenous Infusions
3. Second-Look Surgery
4. Transplants (Transplant)
5. Laparotomy